COVID-19 Saliva Screening Test Potential Market (By Location(North America): Travel Stations, Sports Arenas, Concert Halls, Shopping Malls and Centers, Amusement Parks, Corporate Campus Environments, Universities & Colleges, Factories; Location (Other Region): Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities & Colleges, Factories; By Technology: Fluorescence-labeled antigen/antibodies testing,RT-PCR,CRISPR-Cas9; By Mode:Centralized Testing, Decentralized Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global COVID-19 Saliva Screening Test Potential Market, By Location (North America)

7.1.  COVID-19 Saliva Screening Test Potential Market, by Location (North America), 2020-2030

7.1.1.    Travel Stations

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Sports Arenas

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Concert Halls

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Shopping Malls and Centers

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Amusement Parks

7.1.5.1.        Market Revenue and Forecast (2016-2030)

7.1.6.    Corporate Campus Environments

7.1.6.1.        Market Revenue and Forecast (2016-2030)

7.1.7.    Universities & Colleges

7.1.7.1.        Market Revenue and Forecast (2016-2030)

7.1.8.    Factories

7.1.8.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global COVID-19 Saliva Screening Test Potential Market, By Location (Other Region)

8.1.  COVID-19 Saliva Screening Test Potential Market, by Location (Other Region), 2020-2030

8.1.1.    Travel Stations

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Sports Arenas

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Entertainment Venues

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Corporate Campus Environments

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Universities & Colleges

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Factories

8.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global COVID-19 Saliva Screening Test Potential Market, By Technology

9.1.  COVID-19 Saliva Screening Test Potential Market, by End User, 2020-2030

9.1.1.    Fluorescence-labeled antigen/antibodies testing

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    RT-PCR

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    CRISPR-Cas9

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global COVID-19 Saliva Screening Test Potential Market, By Mode

10.1.        COVID-19 Saliva Screening Test Potential Market, by Mode, 2020-2030

10.1.1.  Centralized Testing

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Decentralized Testing

10.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global COVID-19 Saliva Screening Test Potential Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Location (North America) (2016-2030)

11.1.2.  Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.1.3.  Market Revenue and Forecast, by Technology(2016-2030)

11.1.4.  Market Revenue and Forecast, by Mode (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.1.5.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.1.6.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Location (North America) (2016-2030)

11.2.2.  Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.2.3.  Market Revenue and Forecast, by Technology(2016-2030)

11.2.4.  Market Revenue and Forecast, by Mode (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.2.5.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.2.6.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.2.7.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.2.8.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Location (North America) (2016-2030)

11.3.2.  Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.3.3.  Market Revenue and Forecast, by Technology(2016-2030)

11.3.4.  Market Revenue and Forecast, by Mode (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.3.5.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.3.6.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.3.7.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.3.8.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Location (North America) (2016-2030)

11.4.2.  Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.4.3.  Market Revenue and Forecast, by Technology(2016-2030)

11.4.4.  Market Revenue and Forecast, by Mode (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.4.5.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.4.6.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.4.7.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.4.8.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Location (North America) (2016-2030)

11.5.2.  Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.5.3.  Market Revenue and Forecast, by Technology(2016-2030)

11.5.4.  Market Revenue and Forecast, by Mode (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.5.5.4.      Market Revenue and Forecast, by Mode (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Location (North America) (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Location (Other Region) (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Technology(2016-2030)

11.5.6.4.      Market Revenue and Forecast, by Mode (2016-2030)

Chapter 12.  Company Profiles

12.1.              ARUP Laboratories

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Vatic Health

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              MOgene

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Psomagen Inc.

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              DxTerity Diagnostics, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Ambry Genetics

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Fluidigm Corporation

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Phosphorus Diagnostics LLC

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Gravity Diagnostics

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           DNA Genotek, Inc.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Quidel Corporation

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Abbott

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           LumiraDX

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           FluroTech Ltd.

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms